Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation

Peter R. Bergethon, Tony Sabin, David Lewis, +3

Neurology

A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Luis Paz‐Ares, Beatrix Bálint, Richard H. De Boer, +11

Journal of Thoracic Oncology

Randomized Phase 2MedicinePharmacologyPathologyImmune Checkpoint Inhibitor +6

Diabetic Truncal Polyneuropathy

Stephen G. Waxman, Tony Sabin

Archives of Neurology

Diabetic Truncal PolyneuropathyDiabetesAdvanced Distal PolyneuropathyDiabetic NeuropathyNeuropathic Pain +9

Tonic Focal Seizures in Nonketotic Hyperglycemia of Diabetes Mellitus

Nagagopal Venna, Tony Sabin

Archives of Neurology

<b>bcrm</b>: Bayesian Continual Reassessment Method Designs for Phase I Dose-Finding Trials

Michael Sweeting, Adrian Mander, Tony Sabin

Journal of Statistical Software

Bayesian StatisticDose-finding TrialsOptimal Experimental DesignTreatment Plan EvaluationOncology +15

A phase Ib study to evaluate the safety and efficacy of AMG 655 in combination with gemcitabine (G) in patients (pts) with metastatic pancreatic cancer (PC)

Hedy L. Kindler, Lawrence Garbo, John Stephenson, +5

Journal of Clinical Oncology

ApoptosisImmunologyImmunoeditingPathologyCell Death +19

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

John D. Isaacs, Sarah Brockbank, Ayako Wakatsuki Pedersen, +147

Scientific Data

Safety and efficacy of AMG 655 in combination with paclitaxel and carboplatin (PC) in patients with advanced non-small cell lung cancer (NSCLC)

Luis Paz‐Ares, J.M. Sanchez Torres, Iván Díaz-Padilla, +7

Journal of Clinical Oncology

MedicineE19048 BackgroundApoptosisPharmacologyImmunology +13

A Quantitative Process for Enhancing End of Phase 2 Decisions

Tony Sabin, James Matcham, Sarah Bray, +2

Statistics in Biopharmaceutical Research

Preclinical TherapeuticsNew Drug CandidatesBehavioral Decision MakingClinical EndpointDecision Analysis +26

Predictive value of Fc gamma receptor IIIa genotype in response to conatumumab in three phase II studies.

Yang Pan, Vincent Haddad, Tony Sabin, +6

Journal of Clinical Oncology

ImmunologyPathologyPredictive ValueImmunotherapeuticsImmunotherapy +20